Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Okla State Med Assoc ; 101(2): 35-7, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18361032

ABSTRACT

Gastrointestinal stromal tumor (GIST) is a submucosal tumor which is most commonly found in the stomach and less commonly in small bowel. Small bowel GIST can be difficult to diagnose by conventional imaging and endoscopy techniques. We report a case of obscure GI bleeding due to a stromal tumor (GIST) of the jejunum diagnosed by video capsule endoscopy.


Subject(s)
Capsule Endoscopy , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Stromal Tumors/diagnosis , Jejunal Neoplasms/diagnosis , Aged, 80 and over , Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Stromal Tumors/complications , Gastrointestinal Stromal Tumors/physiopathology , Humans , Jejunal Neoplasms/complications , Jejunal Neoplasms/physiopathology , Male
3.
Curr Treat Options Gastroenterol ; 9(2): 157-66, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16539876

ABSTRACT

Although upper gastrointestinal (GI) bleeding from stress-related mucosal disease (SRMD) in critically ill patients is common, significant bleeding with hemodynamic instability is not. Risk factor assessment can assist in identifying patients with a greater likelihood of developing significant SRMD. Prophylaxis against stress ulcer bleeding with luminal agents (eg, antacids and sucralfate) or drugs that inhibit acid secretion (eg, histamine 2-receptor antagonists and proton-pump inhibitors) can reduce major bleeding but has little or no effect on mortality. Currently, the mainstays of prophylactic therapy for SRMD are intravenously administered H2RAs and PPIs. Wider usage of PPIs reflects their enhanced efficacy in suppressing acid secretion as well as lack of tolerance for H2RAs. Guidelines for the prophylactic use of H2RAs or PPIs in treatment of SRMD will require large, randomized studies that also examine cost effectiveness of individual strategies.

4.
Dig Dis Sci ; 51(2): 274-81, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16534669

ABSTRACT

Epidermal growth factor (EGF) and transforming growth factor alpha (TGFalpha) have been shown to inhibit gastric acid secretion through stimulation of the EGF receptor (EGFR). In this study we examined in vivo the effects of inhibition of the EGFR on histamine-stimulated acid secretion in the rat. Submaximal (1.5 mg/kg/hr) histamine-stimulated acid secretion was measured (microEq H(+)/2 hr) during infusion of EGFRtk inhibitors and ranitidine in anesthetized rats. EGFR phosphorylation in gastric mucosal tissue lysates was measured by Western blot analysis. Submaximal histamine-stimulated acid secretion was increased significantly by the EGFR inhibitors tyrphostin (Tyr) A46 and Tyr AG1478. Tyr A46 prevented TGFalpha (10 microg/kg/hr)-mediated inhibition of maximal (5.0 microg/kg/hr) histamine-stimulated acid output. Histamine caused a fourfold increase in EGFR phosphorylation which was inhibited by both Tyr and ranitidine. We conclude that the EGFRtk inhibitors, Tyr A46 and Tyr AG1478, significantly increased submaximal histamine-stimulated acid output and Tyr A46 prevented TGFalpha inhibition of histamine-stimulated acid secretion. These observations suggest that the EGFR is involved, in vivo, in the regulation of gastric acid secretion.


Subject(s)
ErbB Receptors/antagonists & inhibitors , ErbB Receptors/physiology , Gastric Acid/metabolism , Tyrphostins/pharmacology , Animals , Histamine , Histamine H2 Antagonists/pharmacology , Male , Phosphorylation/drug effects , Quinazolines , Ranitidine/pharmacology , Rats , Rats, Sprague-Dawley , Transforming Growth Factor alpha/physiology
5.
Gastrointest Endosc ; 62(6): 886-91, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16301032

ABSTRACT

BACKGROUND: Colonic hamartomas are uncommon in adults. The aims of this study were to determine (1) the prevalence of colonic hamartomas in an adult population undergoing colonoscopy and (2) the clinical, endoscopic, and histologic features of colonic hamartomas in adult patients. METHODS: A pathology database identified 19 adult patients of 12,707 patients with colonic hamartomas in the 11-year study period from January 1992 to October 2002. An endoscopic computer database provided information about the number of colonoscopies performed and the presence or the absence of colonic polyp(s) in study patients. Charts of patients with colonic hamartomas were reviewed, and clinical and demographic data were collated. RESULTS: Nineteen patients were found to have colonic hamartomas. The mean age of these patients was 55 years, with an age distribution ranging from 25 to 81 years. The prevalence of colonic hamartomas in this study population was 0.15%. The prevalence of hamartomas in patients with colon polyps at index colonoscopy was 0.073%. Colonic hamartomas were more common in men than in women. The indication for colonoscopy for the majority (68%) of patients was hematochezia or the presence of occult blood in the stool. Three fourths of the polyps were greater than 1 cm in diameter, and 89% were pedunculated. Two thirds of the hamartomatous polyps were localized to the rectosigmoid region. Endoscopic characteristics of hamartomas were indistinguishable from adenomas. CONCLUSIONS: Colonic hamartomas in adults are rare. They tend to be single, pedunculated, and localized predominantly in the rectosigmoid region. Endoscopic resection of colonic hamartomas was successful in all patients.


Subject(s)
Colonic Diseases/diagnosis , Hamartoma/diagnosis , Adult , Aged , Aged, 80 and over , Colonic Diseases/complications , Colonic Diseases/pathology , Colonic Diseases/surgery , Colonic Polyps/complications , Colonic Polyps/pathology , Colonoscopy , Female , Hamartoma/complications , Hamartoma/pathology , Hamartoma/surgery , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...